Tag Archives: PBS

Guild Dinner: Pharmacy gets bipartisan support

The importance of community pharmacy in Australia was strengthened as Pharmacy Guild of Australia President George Tambassis highlighted recent successes, outlined strategic initiatives and thanked Government leaders for their continued support for community pharmacy. “This is our opportunity to acknowledge the tremendous working relationships we have with all sides of …

Read More »

Simponi listing for non-radiographic axial spondyloarthritis

The federal government has opened a new front in the treatment of inflammatory arthritis, making the first ever medicine available on the PBS for people with a hidden form of arthritis where their immune system attacks the spine. Medical experts, patient groups and the Janssen Pharmaceutical Companies of Johnson & …

Read More »

Montelukast safety review

The TGA is undertaking additional risk-mitigation activities following a new safety review of  asthma medication montelukast. The government had requested the TGA conduct a safety review of the drug following reports in the media of serious neuropsychiatric events occurring in association with montelukast in children and adolescents. The review evaluated …

Read More »

Monopolies threat to PBS medicines access: NPSA

Without urgent action to stamp out monopolies in the nation’s medicine supply chain, access to essential medicines could be jeopardised and people living in remote and regional areas could end up paying more for PBS medicines than those in urban centres, according to the National Pharmaceutical Services Association. NPSA Chair Mark …

Read More »

NPS Medicinewise gets certainty of funding

NPS MedicineWise has welcomed the budget’s four years of Commonwealth funding for the continuation of its work to improve quality use of medicines and medical tests. “Quality use of medicines and medical tests remains a cornerstone of quality healthcare and we’re pleased the Australian government has reaffirmed its ongoing commitment …

Read More »